Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H22N2O2 |
| Molecular Weight | 262.3474 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)COC1=CC=CC2=C1C=C(C)N2
InChI
InChIKey=NXWGWUVGUSFQJC-UHFFFAOYSA-N
InChI=1S/C15H22N2O2/c1-10(2)16-8-12(18)9-19-15-6-4-5-14-13(15)7-11(3)17-14/h4-7,10,12,16-18H,8-9H2,1-3H3
| Molecular Formula | C15H22N2O2 |
| Molecular Weight | 262.3474 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Mepindolol is a selective beta1-adrenoreceptor blocker with intrinsic sympathetic activity. Treatment with mepindolol dose not significantly affect the lipid levels - the total cholesterol in plasma was decreased by mepindolol but HDL-cholesterol increased. During beta-receptor blockade with mepindolol-sulfate angina was compensated, the unfavourable hemodynamic effects seen during placebo did not occur. No signs of congestive heart failure were found during mepindolol-sulfate-therapy. Mepindolol-sulfate showed a pronounced blood-pressure lowering effect.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis. | 2008-04-24 |
|
| Transdermal delivery of beta-blockers. | 2006-05 |
|
| Role of chemical structure in stereoselective recognition of beta-blockers and H1-antihistamines by human serum transferrin in capillary zone electrophoresis. | 2006-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3759280
10 mg/day for three months
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:46:38 GMT 2025
by
admin
on
Wed Apr 02 09:46:38 GMT 2025
|
| Record UNII |
00Q31ER368
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
||
|
WHO-ATC |
C07AA14
Created by
admin on Wed Apr 02 09:46:38 GMT 2025 , Edited by admin on Wed Apr 02 09:46:38 GMT 2025
|
||
|
WHO-VATC |
QC07AA14
Created by
admin on Wed Apr 02 09:46:38 GMT 2025 , Edited by admin on Wed Apr 02 09:46:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C84659
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
DB13530
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
29518
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
00Q31ER368
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
71698
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
4001
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
100000081477
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
245-831-1
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
C015340
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
23694-81-7
Created by
admin on Wed Apr 02 09:46:38 GMT 2025 , Edited by admin on Wed Apr 02 09:46:38 GMT 2025
|
PRIMARY | |||
|
DTXSID40865110
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
m7193
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
1697
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
MEPINDOLOL
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL65717
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
SUB08750MIG
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |